Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors

Viral entry inhibitors are of great importance in current efforts to develop a new generation of anti-influenza drugs. Inspired by the discovery of a series of pentacyclic triterpene derivatives as entry inhibitors targeting the HA protein of Influenza Virus, we designed and synthesized 32 oleanolic acid (OA) analogues in this study by conjugating different Amino acids to the 28-COOH of OA. The Antiviral activity of these compounds was evaluated in vitro. Some of these compounds revealed impressive anti-influenza potencies against influenza A/WSN/33 (H1N1) virus. Among them, compound 15a exhibited robust potency and broad Antiviral spectrum with IC₅₀ values at the low-micromolar level against four different influenza strains. Hemagglutination inhibition (HI) assay and docking experiment indicated that these OA analogues may act in the same way as their parent compound by interrupting the interaction between HA protein of Influenza Virus and the host cell sialic acid receptor via binding to HA, thus blocking viral entry.

Amino acids; Entry inhibitor; Hemagglutinin; Influenza A virus; Oleanolic acid.